Loading…

Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease

One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent this drawback, the use of multi-target-directed ligands (MTDLs) has recently been proposed as a means of si...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2007-10, Vol.50 (20), p.4882-4897
Main Authors: Bolognesi, Maria Laura, Banzi, Rita, Bartolini, Manuela, Cavalli, Andrea, Tarozzi, Andrea, Andrisano, Vincenza, Minarini, Anna, Rosini, Michela, Tumiatti, Vincenzo, Bergamini, Christian, Fato, Romana, Lenaz, Giorgio, Hrelia, Patrizia, Cattaneo, Antonino, Recanatini, Maurizio, Melchiorre, Carlo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One of the characteristics of Alzheimer's disease (AD) that hinders the discovery of effective disease-modifying therapies is the multifactorial nature of its etiopathology. To circumvent this drawback, the use of multi-target-directed ligands (MTDLs) has recently been proposed as a means of simultaneously hitting several targets involved in the development of the AD syndrome. In this paper, a new class of MTDLs based on a polyamine−quinone skeleton, whose lead (memoquin, 2) showed promising properties in preclinical investigations (Cavalli et al. Angew. Chem., Int. Ed. 2007, 46, 3689−3692), is described. 3 − 29 were tested in vitro against a number of isolated AD-related targets, namely, AChE and BChE, and Aβ aggregation (both AChE-mediated and self-induced). Furthermore, the ability of the compounds to counteract the oxidative stress in a human neuronal-like cellular system (SH-SY5Y cells) was assayed, in both the presence and absence of NQO1, an enzyme able to generate and maintain the reduced form of quinone.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm070559a